EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER – ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER – EUROPEAN ORGANI (0408292992)
| Name of the pharmaceutical or medical device company having made premiums and benefits | Donations and grants that support healthcare | Contribution to costs of scientific events | Fees for services and consultancy | |||
|---|---|---|---|---|---|---|
| Sponsorship agreements to manage a scientific meeting | Registration fees | Travel and accommodation | Fees | Payment and reimbursement of expenses | ||
| ABBVIE | 15.000,00 € | |||||
| AMGEN | 128,60 € | |||||
| ASTRAZENECA | 65.000,00 € | 90.000,00 € | ||||
| BRISTOL – MYERS SQUIBB BELGIUM | 508,00 € | |||||
| DAIICHI SANKYO BELGIUM | 25.000,00 € | |||||
| ELI LILLY BENELUX | 15.000,00 € | |||||
| GILEAD SCIENCES BELGIUM | 23.000,00 € | |||||
| JANSSEN-CILAG | 10.000,00 € | |||||
| JAZZ PHARMACEUTICALS NETHERLANDS B.V. | 5.400,00 € | |||||
| MSD BELGIUM | 10.180,00 € | |||||
| NOVARTIS PHARMA | 40.000,00 € | |||||
| PFIZER | 8.500,00 € | |||||
| REGENERON IRELAND DESIGNATED ACTIVITY COMPANY (BEFORE: REGENERON IRELAND UNLIMITED COMPANY) | 10.000,00 € | |||||
| ROCHE | 67.000,00 € | |||||
| SASU EXACT SCIENCES FRANCE SAS | 107.900,00 € | |||||
| TAKEDA BELGIUM | 25.000,00 € | |||||
A question or comment on premiums and benefits published about you? Click here.
| Name of the pharmaceutical or medical device company having made premiums and benefits | Donations and grants that support healthcare | Contribution to costs of scientific events | Fees for services and consultancy | |||
|---|---|---|---|---|---|---|
| Sponsorship agreements to manage a scientific meeting | Registration fees | Travel and accommodation | Fees | Payment and reimbursement of expenses | ||
| AMGEN | 44.000,00 € | |||||
| ASTRAZENECA | 55.000,00 € | |||||
| BAYER | 5.000,00 € | |||||
| BEIGENE INTERNATIONAL | 185.650,00 € | |||||
| BOEHRINGER INGELHEIM | 15.000,00 € | |||||
| DAIICHI SANKYO BELGIUM | 50.000,00 € | |||||
| ELI LILLY BENELUX | 48.700,00 € | |||||
| GILEAD SCIENCES BELGIUM | 79.000,00 € | |||||
| KYOWA KIRIN PHARMA B.V. | 8.230,00 € | |||||
| MENARINI BENELUX | 78.000,00 € | |||||
| MERCK | 3.300,00 € | |||||
| MERIT MEDICAL BELGIUM | 20.327,88 € | |||||
| MSD BELGIUM | 24.740,00 € | 22.000,00 € | ||||
| NOVARTIS PHARMA | 200.000,00 € | |||||
| PFIZER | 15.745,91 € | 100.000,00 € | ||||
| REGENERON IRELAND DESIGNATED ACTIVITY COMPANY (BEFORE: REGENERON IRELAND UNLIMITED COMPANY) | 76.260,00 € | |||||
| ROCHE | 73.000,00 € | |||||
| SASU EXACT SCIENCES FRANCE SAS | 10.000,00 € | 663,00 € | ||||
A question or comment on premiums and benefits published about you? Click here.
| Name of the pharmaceutical or medical device company having made premiums and benefits | Donations and grants that support healthcare | Contribution to costs of scientific events | Fees for services and consultancy | |||
|---|---|---|---|---|---|---|
| Sponsorship agreements to manage a scientific meeting | Registration fees | Travel and accommodation | Fees | Payment and reimbursement of expenses | ||
| AMGEN | 8.000,00 € | |||||
| DAIICHI SANKYO BELGIUM | 50.000,00 € | |||||
| EXELIXIS INC | 9.049,84 € | |||||
| GILEAD SCIENCES BELGIUM | 25.000,00 € | 6.000,00 € | ||||
| GLAXOSMITHKLINE PHARMACEUTICALS, EN ABREGE GLAXOSMITHKLINE | 112.500,00 € | |||||
| IPSEN | 10.000,00 € | |||||
| MENARINI BENELUX | 6.000,00 € | |||||
| MERCK | 8.640,00 € | |||||
| NOVARTIS PHARMA | 251.870,00 € | |||||
| PFIZER | 9.307,52 € | 12.000,00 € | ||||
| ROCHE | 149.000,00 € | |||||
| SASU EXACT SCIENCES FRANCE SAS | 71.500,00 € | |||||
| SEAGEN B.V. | 7.500,00 € | |||||
A question or comment on premiums and benefits published about you? Click here.
A user-friendly and efficient search engine allows you to find premiums and benefits which have been granted to healthcare professionals, healthcare organisations and patient organisations.
The different options available to you are:
Why is it that I cannot find my healthcare professional or organisation in the register?
It is possible that you cannot find a healthcare professional or organisation on this platform for one of the following reasons:
- This healthcare professional/organisation has no connection with the industry,
- This healthcare professional/organisation does have a connection with the industry but of another nature than that declared nominatively on our site (eg: within the context of research and development where there is no nominative publication).
Furthermore, it is important to emphasise that it is not because a healthcare professional is not listed in the register that he/she is not formed continuously. If it is true that the costs of participation in scientific events are often supported by industry (subject to compliance with strict legal and ethical rules), this is however not always the case. Healthcare professionals can also ensure their continuing education at their own expense.
Consult the explanatory notes of the companies
(notes summarising the methodologies used in preparing the disclosures and identifying benefits and premiums for each category)